Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases

Increasing clinical and preclinical evidence implicates gut microbiome (GM) dysbiosis as a key susceptibility factor for neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). In recent years, neurodegenerative diseases have been viewed as being driven not sole...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Mingxia, Liu, Chang, Wang, Yulin, Liu, Shuang-Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303039/
https://www.ncbi.nlm.nih.gov/pubmed/37375029
http://dx.doi.org/10.3390/microorganisms11061527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303039/
https://www.ncbi.nlm.nih.gov/pubmed/37375029
http://dx.doi.org/10.3390/microorganisms11061527

Ejemplares similares